Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

NeuroPace, Inc.

NPCENASDAQ
Healthcare
Medical - Devices
$14.09
$-0.03(-0.21%)
U.S. Market opens in 15h 1m

NeuroPace, Inc. (NPCE) Stock Overview

Explore NeuroPace, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap474.4M
P/E Ratio-21.62
EPS (TTM)$-0.68
ROE-1.06%
Fundamental Analysis

AI Price Forecasts

1 Month$15.04
3 Months$14.12
1 Year Target$16.79

NPCE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NeuroPace, Inc. (NPCE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.79.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -21.62 and a market capitalization of 474.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.21%
5-Day Change
4.45%
1-Month Change
-6.38%
3-Month Change
-12.97%
6-Month Change
42.90%
Year-to-Date (YTD) Change
-7.12%
1-Year Change
35.09%
3-Year Change
300.28%
5-Year Change
-43.55%
All-Time (Max) Change
-43.55%

Contact Information

650 237 2700
455 North Bernardo Avenue, Mountain View, CA, 94043

Company Facts

1,840 Employees
IPO DateApr 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions